Trinity Biotech | TRIB - Ebit


Trinity Biotech reported $-1.79M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Abbott USD 1.36B 775M Sep/2026
Bayer EUR 129M 626M Sep/2026
Bio-Rad Laboratories USD 72.6M 750.1M Jun/2026
EDAP TMS EUR -7.37M 2.44M Mar/2026
J&J USD 6.47B 1B Sep/2026
Mesa Laboratories USD 4.45M 2.5M Sep/2024
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Siemens EUR 3.19B 509M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Tosoh JPY 18.21B 12.97B Sep/2026
Trinity Biotech USD -1.79M 481K Mar/2026
Veracyte USD 18.02M 5.94M Sep/2026